Blood test could catch breast cancer early, drug may stop it returning
Disease control
Not yet recruiting
This study looks at whether a drug called abemaciclib can stop breast cancer from coming back in people with HR+/HER2- early breast cancer. After standard treatment, participants get regular blood tests to look for cancer DNA. If the DNA is found, they start taking abemaciclib. T…
Phase: PHASE2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated May 17, 2026 12:46 UTC